Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitrendipine and ACE inhibitors.

A Zanchetti1

  • 1Istituto di Clinica Medica Generale e Terapia Medica, Università di Milano, Italy.

Journal of Cardiovascular Pharmacology
|January 1, 1988
PubMed
Summary

Combining calcium antagonists and angiotensin converting enzyme (ACE) inhibitors offers clinical benefits for hypertension management. This combination potentiates therapeutic effects through multiple mechanisms, enhancing blood pressure control.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat.

Journal of hypertension·2001
Same author

Transient but not sustained blood pressure increments by occupational noise. An ambulatory blood pressure measurement study.

Journal of hypertension·2001
Same author

Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.

Journal of hypertension·2001
Same author

Defining ambulatory and home blood pressure normality: further considerations based on data from the PAMELA study.

Journal of hypertension·2001
Same author

Impact of the Gubbio population study on community control of blood pressure and hypertension. Gubbio Study Research Group.

Journal of hypertension·2001
Same author

Risk assessment and treatment benefit in intensively treated hypertensive patients of the hypertension Optimal Treatment (HOT) study.

Journal of hypertension·2001

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Internal Medicine

Background:

  • Clinical studies demonstrate the utility of combining calcium antagonists and angiotensin converting enzyme (ACE) inhibitors for hypertension.
  • Understanding the synergistic mechanisms between these drug classes is crucial for optimizing antihypertensive therapy.

Purpose of the Study:

  • To elucidate the multifaceted mechanisms underlying the mutual potentiation of calcium antagonists and ACE inhibitors.
  • To review the current understanding of optimal dosing strategies for combined antihypertensive therapy.

Main Methods:

  • Review of existing clinical studies and pharmacological data.
  • Analysis of proposed mechanisms of drug interaction and potentiation.
  • Discussion of the limited information on optimal dose combinations.

Main Results:

  • Calcium antagonists can cause reflex sympathetic activation, which is counteracted by ACE inhibitors.
  • Combined therapy may lead to more balanced arteriolar and venous dilatation compared to calcium antagonists alone.
  • Dihydropyridines facilitate renin release and angiotensin II generation, which is subsequently blocked by ACE inhibitors.

Conclusions:

  • The combination of calcium antagonists and ACE inhibitors offers significant clinical benefits in hypertension treatment due to multiple synergistic mechanisms.
  • Further research is needed to establish optimal dose-response relationships and combinations, especially for fixed-dose formulations.

Related Experiment Videos